Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “folate”

16 pharma patents match "folate" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 16
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 16 pharmaceutical patents matching "folate" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

16 results for “folate” · 30,257 patents in full index Clear search

  1. WO 2026039306

    BÉTAÏNE ET FOLATE POUR FAVORISER LA MATURATION DU CERVEAU D'UN NOURRISSON

    ABBOTT LAB [US] · Granted Feb 19, 2026 · Expires Feb 14, 2046

    granted
  2. US 12427201

    Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates

    Sutro Biopharma, Inc. · Granted Sep 30, 2025 · Expires Sep 25, 2045

    granted
  3. US 12071477

    Anti-folate receptor alpha antibody conjugated with hemiasterlins

    Sutro Biopharma, Inc. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  4. CA 3172190

    COMPOSITION COMPRENANT DU METHYLFOLATE

    ALFASIGMA SPA [IT] · Granted Nov 18, 2021 · Expires Nov 13, 2041

    granted
  5. US 10870625

    Zwitterionic propargyl-linked antifolates useful for treating bacterial infections

    UNIVERSITY OF CONNECTICUT · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted
  6. US 10596270

    Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates

    Sutro Biopharma, Inc. · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted
  7. US 10231974

    Pharmaceutical composition effective in preventing the adverse effects associated with the prolonged use of dihydrofolate reductase inhibitors

    Compass Therapeutics LLC · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted
  8. US 9914773

    Anti-human folate receptor beta antibodies and methods of use

    THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted
  9. US 9562070

    Induction of tumor immunity by variants of folate binding protein

    The Board of Regents of the University of Texas System · Granted Feb 7, 2017 · Expires Feb 2, 2037

    granted
  10. US 9382213

    Heterocyclic and cyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase

    UNIVERSITY OF CONNECTICUT · Granted Jul 5, 2016 · Expires Jun 30, 2036

    granted
  11. US 8871206

    Anti-human folate receptor beta antibodies and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted
  12. US 8853228

    Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase

    UNIVERSITY OF CONNECTICUT · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  13. US 8680319

    Method for producing antifolate agents having glutamic acid part in their structure

    Kocak Farma Ilac ve Kimya Sanayi A.S. · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted
  14. US 8507455

    Folate conjugates

    Alnylam Pharmaceuticals, Inc. · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted
  15. US 8426432

    Inhibitors of dihydrofolate reductase with antibacterial antiprotozoal, antifungal and anticancer properties

    UNIVERSITY OF CONNECTICUT · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted
  16. US 7547759

    Induction of tumor immunity by variants of folate binding protein

    The Board of Regents of the University of Texas System · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted